NIH/NCATS SBIR Grant for Rapid Influenza RNA Diagnosis

CrossLife has recently been awarded a Phase 1 Small Business
Innovative Research (SBIR) grant from NIH/NCATS for Point-of-Care Rapid RNA
Diagnosis of Influenza Virus

https://projectreporter.nih.gov/project_info_description.cfm?aid=9136027&icde=31581506&ddparam=&ddvalue=&ddsub=&cr=5&csb=default&cs=ASC